Diversity of calcium antagonists-Reference-Cited by-同舟云学术

Diversity of calcium antagonists

Published:1997-01 Issue: Volume:19 Page:3-17
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Pitt Bertram

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference92 articles.

1. Clinical pharmacology of calcium antagonists;Dollery;Am J Hypertens,1991

2. The risk of myocardial infarction associated with antihypertensive drug therapies;Psaty;JAMA,1995

3. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease;Furberg;Circulation,1995

4. Long-term survival and use of antihypertensive medications in older persons;Pahor;J Am Geriatr Soc,1995

5. Leader S, Mallick R, Briggs N. Myocardial infarction in newly diagnosed hypertensive Medicaid patients free of coronary heart disease and treated with calcium channel blockers. Am J Med. In press.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions;Signal Transduction and Targeted Therapy;2023-04-20

2. Toxicity evaluation, toxin screening and its intervention of the jellyfish Phacellophora camtschatica based on a combined transcriptome-proteome analysis;Ecotoxicology and Environmental Safety;2022-03

3. Ion channel drug discovery: challenges and future directions;Future Medicinal Chemistry;2012-04

4. Safety and Efficacy of Intravenous Clevidipine for the Perioperative Control of Acute Hypertension;Clinical Medicine Insights: Therapeutics;2011-01

5. Clevidipine: A new intravenous option for the management of acute hypertension;American Journal of Health-System Pharmacy;2010-03-01